This carrier-mediated NE release in protracted myocardial ischemia depends on Na+ entry via NHE activation and is supported by evidence that NHE inhibitors are as effective as NET inhibitors in reducing NE overflow [9]. The gene discussed is SLC9C1; the disease is myocardial ischemia.